THE PROFOUND EFFECT OF LUNG DISEASE ON HUMAN LIFE is reflected by a tremendous socioeconomic burden exceeding 6.6 billion dollars annually in the UK, where pulmonary diseases account for a large percentage of emergency and inpatient visits and ultimately lead to one in five deaths in the UK (22) . Chronic lung diseases can remain asymptomatic for a long time, often having progressed to an advanced stage by the time of diagnosis (12, 37, 51) . At present there is a deficit of appropriate diagnostic tools to effectively detect lung disease at an early stage, to predict its progression and exacerbations, and to monitor the efficacy of treatment strategies (27) . Science and medicine are rapidly evolving to a point to truly allow for precision medicine, central to which is the ability to detect specific signals (biomarkers) that are able to predict outcomes and monitor therapy (1, 23, 36) . The ideal biomarker should have a high sensitivity and specificity for predicting clinical outcome or measuring recovery and be easy to sample, measure, and safely collect as well as be reproducible across multiple sites (17) . Extracellular vesicles (EVs), specifically microparticles (MPs) represent emerging biomarkers that satisfy many of these ideal indices and may be quickly translatable to clinical practice. EVs define a spectrum of small lipid cell-derived vesicles with differing compositions and origins (reviewed in in Refs. 13, 21, and 30) . In the present work, we focused specifically on microparticles (MPs), a subset of EVs of ϳ100-1,500 nm in size that are formed from externalization of inner lipids from the bilipid cell membrane during activation, stress, or apoptosis that are characteristically studded with membrane surface receptors and contain cargos originating from the parent cell that can remain functional in terms of cytokines, proteins, genetic material (micro/mRNA), lipids, or even organelles such as mitochondria (11) .
Although EVs can be detected in nearly all biological fluids (45) , MPs are particularly pertinent to the study of lung diseases, as the high blood flow and vascular surface area as well as easy access to airway-and airspace-derived samples create relevance to MPs in the blood, sputum, or bronchoalveolar lavage (BAL) fluid, something unparalleled by other organs (8, 30, 31, 34) . Pioneering biomarker studies involving MPs in pulmonary conditions include diseases such as pulmonary hypertension (2, 3, 7, 32) , lung cancer (44, 49) , chronic obstructive pulmonary disease (COPD) (42, 43) , and effects of smoking (15, 16, 19) , which showcase MPs as abundant, accessible, and sensitive means of predicting disease while concomitantly hinting at their crucial role as active players in the pathomechanisms of lung disease and their capacity to act as shuttles to deliver therapeutics (30) that differentiate them from other canonical biomarkers. The ability to assess MP phenotypic origin, antigenic composition, and spatial-temporal profiles offers powerful diagnostic and prognostic information but at present desperately lacks accuracy and standardization. The most popular strategy for MP assessment is flow cytometry (FCM). Current FCM analyses, however, have major limitations pertaining to accurate MP gating (identification) and reproducible enumeration to accurately and simply measure MPs in biological fluids due to their small sizes, often approaching the limits of detection of FCM, as well as problems with standardization of measurements in different biological fluids, reproducibility over time, and across different machines. Accordingly, there is a growing need for reliable, standardized, user-friendly, sensitive, and accurate FCM enumeration of MPs that would enable meaningful comparison of MP findings between studies (40) . Present attempts to address this problem include the use of both FCM gating and enumeration beads (4 -6, 10, 24, 35, 40) or fluorescence strategies (28, 29, 33) with labels such as carboxy fluorescein succinimidyl ester (CFSE) (48) or annexin V (4, 24, 38, 39, 41, 50) . Each of these strategies, however, is hampered by major challenges in terms of preanalytical limitations, their sensitivity to detect MPs, their complexity, and suitability across different FCM platforms with differing capacities to measure MPs.
To address these present limitations, we aimed to devise a more accurate and standardized means of gating and enumerating MP measurements in pertinent pulmonary biological fluids that would be compatible with flow cytometers of differing abilities to gate and enumerate MPs. To address this gap, we have created biologically relevant lipid bilayer microspheres (LBMs) that are highly consistent in size (2 m), containing phospholipids and proteins, and have FCM side (SSC) and forward scatter (FSC) characteristics, making them ideal for enumeration and upper gating markers for MP populations. Here, we show that LBMs offer clear advantages compared with current strategies in both gating and enumeration of MPs in different biological fluids (blood, BAL) via FCM analysis and thus present a major advancement for the reproducible and user-friendly assessment of MPs as a biomarker in lung disease.
METHODS

Biological fluids for MP enumeration.
All animal experiments were approved by the St. Michael's Hospital Animal Care Committee. Eight-to 10-wk-old male BALB/c mice (Charles River Laboratories) were housed with free access to water and standard mouse chow. Select mice were given single intraperitoneal (ip) injections of 2 mg/kg lipopolysaccharide from E. coli 0111:B4 (LPS; Sigma-Aldrich) or 0.9% normal saline (NS) as vehicle control 8 h prior to acquisition of BAL and blood samples under anesthesia by 200 mg/kg ip ketamine (Bimeda-MTC, Cambridge, ON, Canada) and 10 mg/kg body wt xylazine (Rompun Bayer, Leverkusen, Germany). Anesthetized mice were tracheostomized and intubated with polyethylene tracheal tubes (Portex Fine Bore Polyethylene Tubing), 0.58 mm ID/0.96 OD (Smith Medical International, Kent, UK). The mice were briefly ventilated with positive pressure volume-controlled ventilation with room air at 110 breaths/min, with tidal volumes of 8 -10 ml/kg for 10 min with a positive end-expiratory pressure of 2 cmH 2O (MiniVent; Harvard Apparatus, Holliston, MA). During that time, a thoracotomy enabled isolation of the left lung by a silk tie around the right lung hilum to allow isolated left lung BAL by a single, slow instillation and subsequent recovery of 500 l of room temperature, sterile, 0.9% NS via a 20-G needle attached to the plastic tracheal tube. Recovered BAL fluid aspirates were consistently Ͼ80% of the instillate with a standard deviation of 3.7%. BAL fluid was centrifuged at 600 g for 5 min at room temperature to remove cells and debris. Acellular BAL supernatants were frozen at Ϫ80°C prior to analysis. Whole blood was obtained by exsanguination of via cardiac puncture with a 25-gauge needle in anesthetized mice, heparinized with 50 U/ml unfractionated heparin (Pharmaceutical Partners of Canada, Richmond Hill, ON, Canada), collected into citrated tubes, and centrifuged at 600 g for 5 min to allow separation of plasma from cellular blood fractions. Acellular mouse plasma samples were frozen at Ϫ80°C until time of analysis. Thawed acellular samples were subsequently spun at 2,500 g for 15 min at room temperature prior to dilution and acquisition by FCM. Thawed 2,500-g centrifuged samples were devoid of events with forward and side scatter properties characteristic of platelets (data not shown). Differences in MP counts between individual measurements and experiments reflect the natural variation of MPs in BAL and plasma samples from different animals. MPs were additionally generated from cell culture supernatants from commercially available LONZA (Rochester, NY) mesenchymal stem cells (MSCs) grown as 32 ϫ 10 6 cells/flask and passaged once in serum-free media MSC NutriStem XF Basal Medium (Biological Industries Israel Beit-Haemek) at 37°C, with 4% CO2 generously provided by Dr. Duncan Stewart (Ottawa Hospital Research Institute, Ottawa, ON, Canada). All MP containing samples were diluted in sterile 200-nm filtered annexin V staining buffer (10 mMol/l HEPES, 140 mMol/l NaCl, and 2.5 mMol/l CaCl2, pH 7.4, in ddH20; Bioshop, Burlington, ON, Canada) prior to being assessed by FCM.
Lipid bilayer microspheres. LBMs for gating and enumeration of MPs were generated using a process that is presently protected under an intellectual property agreement. LBMs are small, biologically inert spheroid constructs with a protein and lipid bilayer that mimics the lipid and dual leaflet composition of a physiological cell membrane. LBMs were suspended in sterile PBS at a known concentration determined by both hemocytometer counting and enumeration by sorting using a Becton-Dickinson (BD) FACS ARIA III. Microscopy (Zeiss LSM 700; Zeiss, North York, ON, Canada) at 60ϫ oil immersion revealed the LBMs to be 2.15 Ϯ 0.4 m in diameter. LBM characteristics (counts, size, light scatter properties) were not affected by repeated freeze-thaw cycles at Ϫ80°C or extended storage Ͼ6 mo at 4°C (data not shown).
Flow cytometry. Unless stated otherwise, samples were analyzed on a BD FACS ARIA III SORP with a 130-mW, 488-nm laser (BD Biosciences, San Jose, CA), with a 100-m nozzle, sheath pressurized at 20 psi, no neutral density (ND) filters, fournier optical transformation unit, and a small particle detection module allowing MP enumeration via several strategies. When indicated, alternative flow cytometers were used, such as a MacsQuant [25-mW, 488-nm laser, forward scatter (FSC) photomultiplier tube (PMT); Miltenyi Biotech, San Diego, CA], a BD Fortessa X-20 SORP with small particle detection module, a fournier optical transformation unit, a variable laser power output controlled by Coherent Connect 3 software (200 mW 488 nm laser, FSC PMT; BD Biosciences, San Jose, CA), a BD FACS Calibur with a 15-mW, 488-nm laser and FSC photodiode (BD Biosciences), or a Beckman Coulter Cytoflex (50-mW, 488-nm laser FSC fiber array photo diode; BC, Mississauga, ON, Canada) for MP measurement. Diluted MP samples (1:100) were measured over 120 -240 s to reduce confounding "dead space" error in gravimetric consumption after running a 100-nm filtered buffer and filtered (Ͻ200 nm) sheath fluid (BD Biosciences) for a period of 30 -60 min to minimize instrument background noise. Data were collected with each cytometer operating at its slowest settings for longer sampling durations (Ͼ120 s/sample), using low-pressure sample pressure or run speed (20 psi or the lowest run setting) at constant flow rates to maximize sensitivity and reduce coincident events. FCM calibration was conducted daily on each cytometer.
Flow cytometric microparticle gating. Establishing a window of accurate observation for counting and characterizing MPs by FCM involved biexponential forward and side scatter plots in conjunction with either light scatter-(small bead gate or large LBM gate) or fluorescence-based (fluorescence gate) gating (Fig. 1) .
Light scatter MP gating involved the use of two different strategies. First, certain MPs containing samples were gated by small-particle calibration gating beads (polystyrene microspheres; 300, 500, 800, and 1,000 nm in size; BD Biosciences), where the 300-and 800-nm beads established the lower and upper gating limits, respectively (small bead gate; Figs. 1A, 2, A and C, 3, B and C, and 9B). Alternatively, MP-containing samples were gated by light scatter based on excluding debris/instrument noise on the lower limit and LBM gating particles (2, 1C ). Background contribution from gating aids such as beads and LBMs showed a higher rate of false-positive events in the small bead gate compared with the large LBM gate (Fig. 1, A and B) , giving a first indication of the superiority of LBM-based strategies over conventional bead-based approaches.
For select experiments, MPs were labeled by annexin V conjugated to phycoerythrin (BD Biosciences) 10 min prior to FCM analysis. Appropriate controls containing 5 mmol/l of the Ca 2ϩ chelator EDTA (Sigma-Aldrich) were performed, which eliminated fluorescent events within the MP gates, in line with the requirement annexin V labeling for Ca 2ϩ (data not shown). Flow cytometric enumeration of microparticles. FCM enumeration of MPs (MP/l) sampled from diluted BAL, plasma, and cell culture supernatants was obtained by either 1) gravimetric consumption during sample uptake, 2) enumeration of known spiked concentrations of LBMs, or 3) enumeration by popular commercial counting beads (rainbow and ultrarainbow beads; Spherotech, Lakeforest, IL), Fluoresbrite YG carboxylate microspheres (Polysciences beads, 500 nm; Polysciences, Warrington, PA), and Trucount beads (BD Biosciences).
Gravimetric consumption during FCM measurement took into account the specific gravity of the diluted biological sample being assessed, namely 1.0095 for BAL, 1.014 for plasma, and 1.006 for cell culture supernatant. The concentration of MPs (MPs/l) was then calculated as Finally, known concentrations of four different popular commercially obtained counting beads were used for enumeration; rainbow and ultrarainbow beads, Fluoresbrite YG carboxylate microsphere beads (Polysciences beads; 500 nm), and Trucount beads were spiked in diluted biological fluid samples, and MP concentration was calculated as MP/l ϭ (no.of MP counted from bead gate) ϫ (no.of enumeration beads spiked in sample/ml) ([no.of enumeration beads counted] ϫ 1,000 l/ml) MP counts were generated by multiplexed analyses from the same tube(s) to eliminate intersample variability when comparing enumeration strategies.
Calibration controls for flow cytometric assessment of MPs. When assaying MPs in biological fluids, appropriate controls are essential to ensure extracellular vesicles are being measured and not similarly sized aggregates, multiple events, or debris. To test the contribution of non-MP events such as immune complexes or debris with light scatter-based gating, we selectively depleted MPs by the addition of 0.05% Triton X-100 (Sigma-Aldrich) to samples. Triton X-100 treatment reduced MP counts for all gating strategies assessed with all flow cytometers used in the study by Ͼ87% (for ARIA III, see Fig. 1 ; other data not shown), confirming that non-MP events did not contribute significantly to MP gated counts.
Serial dilutions (1:10, 1:100, and 1:1,000) were performed to assess coincidence ("swarm detection", i.e., measurement of MP aggregates or multiple MPs passing the detector at the same time). There was no change in MP counts across dilutions in biological fluids an order of magnitude above and below the standard utilized dilution (data not shown).
Statistical analysis. All data are given as means Ϯ SD. Comparisons between groups were performed by two-tailed unpaired Student's t-test (P Ͻ 0.05) or two-way analysis of variance (P Ͻ 0.05). Different enumeration strategies were compared by linear regression analysis, correlation coefficient, and Bland-Altman analysis (9) . All statistical tests were completed with Prism software 5.00 (Graphpad Software).
RESULTS
Different gating and enumeration strategies impact microparticle counts in biological fluids.
In a first set of experiments, we compared different MP gating and enumeration methods against gravimetric counting, which served as a gold standard, within a single sample of BAL, as it is a commonly used biological fluid central to the study of lung disease. When using the small bead gate (Fig. 2C) or the large LBM gate (Fig.  2D) within the same diluted BAL sample, enumeration by beads was less accurate in counting total events compared with LBM-based counts. LBM-based counts most closely resembled the gold standard (gravimetric counting) in terms of relative differences between the different methods being examined. Although there were statistically significant differences seen between rainbow beads or LBMs each compared with gravimetric MP estimates, but not ultrarainbow beads and gravimetric counts (due to the large variability of ultrarainbow bead MP estimates), of all the techniques examined the LBMs most closely approximated gold standard gravimetric counts. and large LBM gate (B, large box) is shown with MPs depicted in blue, instrument noise in black, and LBMs in red. Analyses were performed on identical sample tubes gated either by the small bead gate (C) or the large LBM gate (D) and enumerated by the indicated beads or the LBMs in a multiplexed manner to reduce intersample variability. Compared with gravimetric consumption, rainbow beads significantly undercounted whereas and ultrarainbow beads overcounted within the same sample independent of whether the small bead gate or the larger LBM-based gate was utilized. LBM-based enumeration estimates more closely resembled gravimetric consumption counts than bead-based enumeration techniques yet significantly exceeded gravimetric counts in both the small bead gate and the large LBM gate. Data are given as means Ϯ SD; n ϭ 5 each, *P Ͻ 0.05.
Specifically, counting beads either undercounted (rainbow beads) or overcounted (ultrarainbow beads) compared with gravimetric counts, regardless of whether the large or small light scatter based gates were used. Next, we compared these light scatter gating and enumeration techniques (small bead and large LBM gates) with CFSE fluorescence gating. Fluorescence gating showed a tendency to enumerate more MPs compared with the light scatter based small bead gate for all three enumeration strategies; this trend reached significance in the case of the LBM-based enumeration (Fig. 3A) . Conversely, fluorescence gating tended to count fewer MPs compared with light scatter-based large LBM gates, which again reached significance for LBM-based enumeration (Fig. 3B) .
Having thus established that the most effective gating method using high-sensitivity FCM was large LBM gates, we next compared different enumeration strategies in different biological fluids (BAL, plasma, and cell culture supernatants) with respect to their accuracy and reproducibility over a range of different MP concentrations. To this end, we applied the large LBM gate strategy that had provided the largest window for MP detection in BAL and compared gravimetric, LBMbased, and popular commercial enumeration bead strategies by Bland Altman analysis (9) . Because of their tendency to significantly overcount MPs, ultrarainbow enumeration beads were not pursued in subsequent analyses. In BAL fluid, strong linear correlation with gravimetric consumption was evident for all tested enumeration strategies, i.e., Rainbow beads (r 2 ϭ 0.99), LBMs (r 2 ϭ 0.99), Polysciences beads (r 2 ϭ 0.96), and Trucount beads (r 2 ϭ 0.93). However, Bland Altman analysis revealed distinct differences between these four strategies (Fig.  4) . Bland Altman plots display the difference between the measured results of two methods (a tested method and a gold standard; gravimetric counting) against the average of both methods. The mean difference (gravimetric counts, counts from tested method) on the y-axis was closest to 0 for LBMs, which indicates the least-fixed bias of the four techniques compared with the gravimetric results. Furthermore, LBMs had the smallest limits of agreement (average difference Ϯ 2 standard deviations on the y-axis), indicating good reproducibility within BAL fluid across the range of concentrations assessed. In contrast, all three bead-based techniques showed relatively large limits of agreement and a concentration-dependent bias, visible as an upward trend in measured values as the MP concentration increased, indicating an increasing inability B: the fluorescent CFSEϩ MPs (green) were then depicted as a back-gated color overlay on a dot plot using light scatter gating with side vs. forward light scatter with an overlaid small bead gate (small top rectangle) and large LBM gate (larg bottom rectangle) with MPs depicted in blue, instrument noise in black, rainbow counting beads in purple, and LBMs in red. C and D: with the small bead gate (C), many MPs fell outside the detection gate, resulting in smaller MP counts than observed in the large LBM gate (D) or the fluorescence gate. Rainbow bead-based enumeration had a tendency to undercount whereas ultrarainbow beads were prone to overcounting relative to LBMs in both the small bead gate and large LBM gate. All light scatter-gated counting had close agreement with fluorescence-gated counting when MP counts were assayed within the large LBM gate, except for LBM gating, which counted more MPs than fluorescence gating. In the small bead gate, fluorescence-gated counting, which was not constrained by the smaller bead-based gate limits, consistently overcounted MP events in relation to counts generated by light scatter-based counting, which became statistically significant for LBM-based gating. Analyses were performed on identical sample tubes gated on either the large LBM gate or the small bead gate and CFSE positivity with LBM-based enumeration in a multiplexed manner to reduce intersample variability. Data are given as means Ϯ SD; n ϭ 5. *P Ͻ 0.05. to accurately count MPs at higher concentrations (Fig. 4A ). Next, we tested the enumeration capacity of the above methods in plasma (Fig. 5) . The correlations between gravimetric consumption and LBMs (r 2 ϭ 0.83), Rainbow beads (r 2 ϭ 0.51), Polysciences beads (r 2 ϭ 0.66), and Trucount beads (r 2 ϭ 0.66) were again high, albeit overall less so than for BAL. However, in plasma, both LBMs and beads had wider limits of agreement than in BAL, indicating greater variability across different concentrations (Fig. 4) . LBMs and Polyscience beads showed the least-fixed bias, yet limits of agreement for Polyscience beads were almost twice as large as for LBMs. Of the four methods tested, Trucount beads had the narrowest limits of agreement in plasma, yet their fixed bias was greater than that of LBMs. In cultured cell supernatants (Fig. 6) , there was again a good correlation between gravimetric consumption and LBMs (r 2 ϭ 0.74), Rainbow beads (r 2 ϭ 0.96), Polysciences beads (r 2 ϭ 0.70) and Trucount beads (r 2 ϭ 0.71). LBMs performed best in terms of fixed bias and limits of agreement, closely followed by Polysciences beads and markedly superior to Rainbow and Trucount beads (Fig. 4) . Taken together, these quantitative comparisons reveal that the various enumeration strategies assessed with the large LBM gate vary in their accuracy between each other as well as within the same enumeration strategy when used in different biological fluids. Notably, LBMs had the least-fixed bias within all fluids examined and the smallest limits of agreement, except for plasma, compared with all three bead-based strategies.
Based on these data, we next probed the ability of LBMs for gating and enumeration of MPs in a preclinical model of murine lung inflammation. To this end, we assessed MP levels in both BAL and plasma from mice treated 8 h prior to sampling with ip injections of either NS or 2 mg/kg body wt LPS. By use of the large LBM gate and enumeration, we detected a marked increase in plasma MP counts in LPS-vs. NS-treated mice, whereas MP counts remained unchanged within BAL (Fig. 7) . Hence, LBM gating and enumeration successfully allowed for semiquantitative assessment of differences in circulating MPs numbers in healthy vs. inflamed mice.
LBMs assist MP gating and enumeration with different flow cytometers and configurations. High sensitivity FCM with the large LBM gate and LBM-based enumeration detects biologically relevant differences in MP counts with a high degree of precision in different biological fluids. Yet to establish the general utility of LBMs for measuring MPs, it is critical to assess how well LBMs perform in different FCM systems with differing capacity to measure MPs. To this end, we compared the ability of different flow cytometers to detect MPs with LBMs. Within the chosen FCM systems, we compared the top two gating strategies tested consisting of both light scatter gating with the large LBM gate and fluorescence gating with CFSE (fluorescence gate) to assess which of these strategies would be most advantageous on each machine for LBMassisted enumeration. Furthermore, we compared the large LBM gate to annexin V fluorescence gating due to its use in previous studies as a means of gating MPs.
Of the cytometers tested with LBM based gating, the ARIA III had the highest MP detection sensitivity in BAL samples, followed by the Cytoflex and X-20, which had higher counts than the Calibur and MacsQuant (Fig. 8A) . Similar trends in sensitivity were seen with CFSE fluorescence gating. Unlike more sensitive FCM systems where the large LBM gate yielded higher MP counts than CFSE fluorescence gating, less sensitive machines such as the Calibur and the MacsQuant yielded higher MP counts with the fluorescence rather than the large LBM gate. Therefore, fluorescence gating on lowerresolution cytometers allows for fluorescent discrimination of smaller MPs that would otherwise be lost in the instrument noise on light scatter gates, whereas more sensitive machines detect more MPs with the large LBM gate compared with the fluorescence gate. We considered that the differences in the abilities of these five instruments to resolve MPs may relate at least in part to their differences in laser power. We thus tested the effect of power of the 488-nm laser within the X-20 on the ability to quantitatively detect MPs by use of the large LBM gate. With decreasing laser power the light scatter sensitivity for detection of MPs decreased linearly (Fig. 8B) , indicating that differences in laser power may contribute markedly to the varying abilities of different cytometers to accurately resolve and enumerate MPs.
Finally, we tested whether gating and enumeration could affect the visibility of annexin V ϩ MPs, as annexin V positivity has historically been used as marker for MPs. To this end, we compared an annexin V fluorescence gate to the large LBM gate in BAL samples over a range of cytometers. Similarly to CFSE gating, annexin V staining showed higher or at least equivalent MP counts compared with light scatter-based large LBM gates for low-sensitivity machines (Calibur, MacsQuant), whereas high-sensitivity instruments (ARIA III, Cytoflex, X-20) conversely yielded higher MP counts with light scatterbased large LBM gates than annexin V fluorescent staining (Fig. 9) .
DISCUSSION
Lipid bilayer microspheres matched with high-sensitivity FCM are capable of more accurately simultaneously gating and enumerating MPs compared with combinations of popular commercial enumeration and gating beads or fluorescence gating combined with LBM enumeration. LBM-based FCM analysis was able to effectively detect elevated MPs between sham-and LPS-treated mouse plasmas. LBMs offer gating advantages for high-sensitivity FCM and an effective enumeration aid for all FCM systems assessed.
The present investigation was driven by the unmet need for more accurate, user-friendly, and cost-effective ways to identify and enumerate MPs in biological samples relevant to lung disease. The characterization of MPs is challenging due to their small size, and there currently exists no gold standard for the detection and analysis of MPs (46) . FCM was chosen in the present study as the means of enumerating MPs because it enjoys the greatest popularity among MP investigators, as it is commonly accessible and able to count large sample numbers and phenotype subpopulations with the use of fluorescently tagged antibodies. FCM, however, is hampered by an inability to discriminate the exact size of biological vesicles and their shape and fundamentally lacks the appropriate reference materials necessary to standardize MP enumeration effectively (24, 28, 48) . Therefore, we aimed to resolve the crucial gap of accurate MP gating and enumeration strategies by use of a novel light scatter strategy that is based on the use of small lipid bilayer microspheres as a reference. Here, we demonstrate that LBMs enhance high-sensitivity FCM for both gating and enumeration of MPs and also benefit older cytometers with limited MP detection capabilities.
FCM enumeration of MPs is challenging, as MPs are frequently smaller than the wavelength of incident laser light and thus invariably cross into background noise at the lower detection limits of cytometers. To overcome limitations with current gating strategies of light scatter bead-based gating (4 -6, 10, 24, 35, 40) or CFSE/annexin V fluorescence gating (4, 24, 38, 39, 41, 48, 50) , we designed a gating strategy based on the use of LBMs that had been engineered specifically for this purpose. With a mean size of 2.15 m, LBMs demarcate Bland-Altman plots depict for each method the difference between the determined counts and the counts measured by the gold standard against the mean count from both techniques. In cell culture supernatants, fixed bias and limits of agreement were smallest for LBMs compared with all 3 bead-based techniques, which in addition showed a tendency toward concentration-dependent bias (rainbow beads, Trucount beads). Data are shown as individual data points from n ϭ 20 different measurements for each comparison. the upper size limit characteristic for MPs (100-1,000 nm). LBMs resemble MPs in their composition of phospholipids and proteins, which is important since refractive indexes, shapes, material composition, and Mie and Rayleigh light scatter are critical in enumerative comparisons (reviewed in Ref. 46 ). Light scatter-based large LBM gates using high-sensitivity FCM facilitated a larger gate for MP observations than commercial beads or fluorescence strategies. This was in part due to measuring down to just above instrument noise at the low end, which expanded the window of observation to capture MP events. This is significant because it allows a disproportionately greater fraction of extracellular vesicles in biological fluids to be measured, which are typically skewed to smaller sized MPs (Ͻ300 nm) (4, 5, 20, 46, 47) . An additional advantage of LBMs is their slightly larger size compared with MPs, which positions them just outside the MP gate as opposed to inside, as seen with most commercial beads, which can add complexity to interpreting MP observations in bead-derived MP gates. Beads are further hindered relative to LBM gating by the fact that different FCM machines resolve beads differently or simply cannot resolve smaller beads adequately (14) . Unlike LBMs, beads are costly as they are either usually bought as a cocktail of different-sized beads or individually to create a custom range of sizes to suit the investigators' needs. Separate gating and counting of beads adds to complexity and cost, unlike the economical duality of LBMs, which serves both tasks simultaneously. It should be noted, however, that despite the demonstrated advantages of LBMs over bead-based strategies, instrument noise defining the lower limit of large LBM gates remains the final hurdle of fully standardized light scatter gated MP enumeration. Instrument noise at the lower MP gate varies between machines, and over time this limits true MP enumeration at present to relative observations between sample groups with LBMs. Although relative counts of Analyses were performed on identical sample tubes that were enumerated in a multiplexed manner to reduce intersample variability. Gating was performed with either LBM-based light scatter gates (large LBM gate; black bars) or fluorescent CFSE ϩ gating (fluorescence gate; gray bars), whereas counting estimates involved enumeration with LBMs. Within individual cytometers, marked differences between light scatter and fluorescence gating were noticeable, with instruments with highsensitivity (ARIA III, X-20, Cytoflex) tending to undercount and instruments with lower sensitivity (Calibur) tending to overcount with fluorescence gating compared with light scatter gating. MP estimates also varied considerably between different cytometers. Data are given as means Ϯ SD; n ϭ 5. *P Ͻ 0.05. B: to assess the influence of different laser powers on this variability, additional MP counts in BAL were determined on a BD X-20 SORP cytometer with light scatter gating using the large LBM gate-and LBM-based enumeration, whereas the forward scatter laser power was titrated to 20, 25, 50, 75 , and 100 mW. MP counts correlated near-linearly with laser power (r 2 ϭ 0.97, P Ͻ 0.05). healthy vs. disease states can easily be accomplished, as evidenced by the detected changes in MPs in LPS-treated mice, multicenter and temporally spaced trials are currently hampered by a lack of reference material to define the lower MP gating boundaries.
Although conventional cytometers assisted by fluorescence gating continue to evolve with better low-end detection limits to allow detection of Ͼ100-nm MP-sized vesicles (4, 5, 48) , in the present study the ARIA III was able to detect even more MPs by the large LBM gate than with fluorescence. Thus a balance exists in which fluorescence-based discrimination provides an advantage if the cytometer in question has significant light scatter resolution limitations, whereas cytometers with superior light scatter sensitivity operate even more effectively without fluorescence discrimination. The ability to detect and enumerate MPs without the use of fluorescence gating may prove particularly useful as 1) it avoids potential measurement error due to nonspecific uptake of fluorescence, 2) it reserves fluorescence channels for phenotypic investigations by key bright fluorophores, 3) it evades false-negative or false-positive results due to poor uptake of fluorescent markers in smaller MPs or formation of fluorescent protein aggregates, including labeling of serum proteins, respectively, and 4) it eliminates problems arising from background fluorescence and the difficulties to washout unbound dye. Like CFSE, annexin V fluorescent gating was advantageous for increasing MP numbers counted with low-but not high-sensitivity FCM. Although annexin V continues to enjoy some popularity as a means of identifying MPs by fluorescence (4), a growing body of data demonstrate that annexin V is not present in all MPs (40) . Although assessment of annexin V positivity remains of interest in the study of lung pathology due to its association with phosphatidylserine, which has procoagulant properties (18, 26) , its usefulness for MP enumeration is limited and inferior to light scatter-based techniques when high-sensitivity FCMs are applied.
Although LBMs and the various bead-based techniques correlated well with gold standard gravimetric counts, there were important divergences in enumeration capabilities when stratified by Bland Altman analyses. In all biological solutions examined, LBMs offered significant advantages for several reasons. An immediate advantage is the shared capacity to both gate and enumerate simultaneously, which reduces cost and complexity, as commercially available beads are typically purchased separately for enumeration or gating. As an enumeration method for MPs in BAL and cell culture supernatant, LBMs were superior to popular counting beads due to their low fixed bias, smaller limits of agreement, and lack of concentration-dependent bias. However, LBMs' advantages were less prominent in plasma, where they were superior in terms of fixed bias but slightly inferior in terms of limits of agreement compared with Rainbow beads and Trucount beads, respectively. Unlike LBMs, bead-based enumeration strategies have additional limitations that vary in severity among the different beads available and in different biological fluids. Beads are plagued with potential high background particulate contamination within MP gates (exemplified in Fig. 1A) , which can lead to overcounting (ultrarainbow beads), possible adherence of beads within the cytometer tubing, large-sized beads that may settle in solution and overestimate the volume analyzed, leading to undercounting MPs (rainbow beads), or beads sized so they are found in MP gates (Polysciences beads), which complicates analysis. Across all biological fluids analyzed, LBMs offered the closest MP counts to the gold standard and offered greater simplicity and fewer false-positive events than beads.
Different biological fluids add challenges to MP enumeration due to their composition, viscosity, cellular endowments, and interactions with FCM systems such as intrinsic autofluoresence differences. In the present study, biological fluids were examined, ranging from the more aqueous low-background serum-free cell culture supernatant to the intermediate BAL and finally, more viscous and protein-rich plasma. Not surprisingly, given the potential for false-positive events due to protein aggregates, plasma proved the most challenging fluid with the widest limits of agreement for all tested MP enumeration strategies, even when taking into account the fact that on average higher MP concentrations were detected in plasma compared with other fluids, which in case of a concentrationdependent bias may contribute to the wider limits of agreement (e.g., in the case of Rainbow beads).
In order for MPs to be meaningful biomarkers, means of comparing and interpreting MP counts among different investigators using different FCM systems is critical (25, 40) . Few studies so far have addressed potential differences between cytometers regarding enumeration of MPs (14, 24, 25, 35 ). LBMs will not resolve variability in MP detection between different FCM systems, which is attributable to hardwarespecific limits of detection and signal noise. Notwithstanding, we show here that current high-sensitivity FCMs equipped with small-particle detection units clearly benefit from LBMs for gating and enumeration, whereas less sensitive instruments did not always benefit from LBM gating, presumably because of a high-light scatter background contribution and lack of adequate sensitivity. Some of these limitations appear to be related to laser power, because when the X-20 laser was modulated from 100 down to 20 mW there was a linear relationship with the number of MPs counted. This relationship of laser power and MP counts was roughly reproduced among the different FCM systems examined with 488-nm laser powers ranging from 130 mW for the ARIA III to 25 and 15 mW in case of the MacsQuant and Calibur, respectively. MP enumeration by low-light scatter sensitivity FCMs using the large LBM gate yielded similar or even lower MP counts than CFSE or annexin V fluorescence counts. Hence, unlike high-sensitivity FCM, which clearly benefits from both LBM gating and enumeration, in FCM with poor light scatter resolution, CFSE fluorescence may help measure "dim" fluorescently positive small vesicles that would otherwise be lost in light scatter background noise (33, 48) . Notably, LBMs still offer the advantage of a means of enumerating MPs within these machines.
Taken together, we report an accurate, reliable, and userfriendly technique for simultaneous light scatter MP gating and enumeration by use of LBMs that is overall superior to conventional bead or fluorescence-based strategies for FCM systems of differing abilities to detect MPs. LBM gating and enumeration detected differences in MPs in different biological compartments in an LPS mouse model, showing their ability to facilitate MP biomarker measurements. In the present study, we focused the use of LBMs on gating and enumeration of MPs in biological fluids pertinent to lung disease. In consideration of the improved performance of LBMs compared with conventional enumeration strategies in different biological fluids, which varied in cellularity and viscosity, it seems fair to speculate that LBMs will likely perform equally well in nonpulmonary settings pertinent to health and disease. As we enter the dawn of precision medicine, MPs are poised to be a key player in driving this next evolution in pulmonary care. LBMs offer a novel powerful means of enhancing our ability to meaningfully determine semiquantitative differences in MPs over time and across different platforms, which in turn begins to unlock their potential as quantitative biomarkers of lung injury or mediators of therapeutic treatment of lung disease.
